Skip to content
Open access · CC-BY via OpenAlex

Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome

Archana Arjunan, Dhiraj Kumar Sah, Minna Woo, Juhyun Song

Cell & Bioscience · 2023 · ▲ 97 citations

Abstract

Neurodegenerative disorders are accompanied by neuronal degeneration and glial dysfunction, resulting in cognitive, psychomotor, and behavioral impairment. Multiple factors including genetic, environmental, metabolic, and oxidant overload contribute to disease progression. Recent evidences suggest that metabolic syndrome is linked to various neurodegenerative diseases. Metabolic syndrome (MetS) is known to be accompanied by symptoms such as hyperglycemia, abdominal obesity, hypertriglyceridemia, and hypertension. Despite advances in knowledge about the pathogenesis of neurodegenerative disorders, effective treatments to combat neurodegenerative disorders caused by MetS have not been developed to date. Insulin growth factor-1 (IGF-1) deficiency has been associated with MetS-related pathologies both in-vivo and in-vitro. IGF-1 is essential for embryonic and adult neurogenesis, neuronal plasticity, neurotropism, angiogenesis, metabolic function, and protein clearance in the brain. Here, we review the evidence for the potential therapeutic effects of IGF-1 in the neurodegeneration related to metabolic syndrome. We elucidate how IGF-1 may be involved in molecular signaling defects that occurs in MetS-related neurodegenerative disorders and highlight the importance of IGF-1 as a potential therapeutic target in MetS-related neurological diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1186/s13578-023-00966-z
Canonical
link ↗
Fetched
2026-11-06 MST

Cite this

APA
Arjunan, A., Sah, D.K., Woo, M., &amp; Song, J. (2023). Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. <em>Cell & Bioscience</em>. https://doi.org/10.1186/s13578-023-00966-z
Vancouver
Arjunan A, Sah DK, Woo M, Song J. Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. Cell & Bioscience. 2023. doi:10.1186/s13578-023-00966-z.
BibTeX
@article{archana2023Identi, title = {Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome}, author = {Archana Arjunan and Dhiraj Kumar Sah and Minna Woo and Juhyun Song}, journal = {Cell & Bioscience}, year = {2023}, doi = {10.1186/s13578-023-00966-z}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings